RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
JiMED is a company specializing in wireless embedded brain-computer interface (BCI) systems that monitor brain activity. It offers a wireless implantable BCI system that utilizes an implanted device in conjunction with artificial intelligence to interpret brain signals. This innovative technology allows individuals with ALS to control the device through thought, significantly enhancing their ability to communicate and improve their quality of life.
Holo Bio is a research and technology firm dedicated to developing biological breeding techniques to tackle global food challenges. The company has created an innovative organism breeding technology that enhances the productivity of the intestinal bacterium GI35, which was discovered in the fish species native to Lake Biwa, Isaza. This bacterium is capable of supplying eicosapentaenoic acid (EPA) from fish, and Holo Bio's work enables the transformation of previously inedible plant fibers into edible forms. Through these advancements, Holo Bio aims to contribute to sustainable food solutions for society.
Enu Pharma is a pharmaceutical company focused on innovative research and the development of advanced medicines aimed at improving global healthcare standards. The company has developed a proprietary nanosome technology designed to assist healthcare professionals in effectively treating challenging diseases. This technology features core metals enveloped in an antiadhesive mixed self-assembled monolayer, which helps prevent non-specific surface protein interactions. By enhancing drug discovery, development, and delivery, Enu Pharma seeks to unlock new therapeutic possibilities and address unmet medical needs.
Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
Rhinoflux is an energy management company that develops efficient thermal management technologies for advanced cooling systems.
OOYOO is a Tech venture, which researches and development of gas separation membranes for carbon dioxide, hydrogen, etc.
Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.
RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Symbiobe is a company that focuses on developing a resource-recycling material production platform aimed at promoting sustainability. By utilizing underexploited natural biomass resources and photosynthetic organisms, the platform offers innovative solutions for greenhouse gas fixation and the production of industrial biopolymers, nitrogen fertilizers, and aquaculture feed. This approach not only enhances the effectiveness of these materials but also supports environmental start-up businesses in obtaining natural and sustainable products. Symbiobe's mission is to advance manufacturing practices globally to ensure a sustainable future for generations to come.
EneCoat Technologies specializes in the development and manufacturing of perovskite solar cells and related materials. The company focuses on creating thin-film solar cells that perform effectively in low-light conditions, aiming to enhance the utilization of natural energy sources while contributing to environmental protection. By commercializing these advanced solar modules, EneCoat seeks to facilitate accessible and efficient solar energy generation for businesses, thereby promoting a sustainable energy future.
Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.
RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Restore Vision is a biotechnology company focused on developing innovative therapies for eye diseases, particularly retinitis pigmentosa. The company specializes in gene therapy, utilizing advanced technology to create therapeutic agents that address intractable eye conditions. Restore Vision's approach involves the use of chimeric rhodopsin genes, which enhance the functionality of conventional rhodopsins, allowing for increased sensitivity in patients. This technology aims to improve treatment outcomes for individuals suffering from various eye disorders, providing new hope for visual restoration.
Melody International is a manufacturing company that specializes in medical equipment designed for remote medical services. The company has developed an advanced fetal monitoring device that assists healthcare professionals during challenging delivery situations. This device includes a fetal heart monitor, a uterine contraction monitor, and a tablet interface. It features a built-in speaker connected to the transducer via the internet, allowing it to function as a fetal Doppler for monitoring pregnancy. This innovation enables women to assess maternal and fetal health conditions even from distant locations, thereby improving access to essential medical care.
QSimulate is a Boston-based company that develops cloud-based quantitative simulation tools aimed at addressing complex challenges in the chemical and pharmaceutical industries. By harnessing the principles of quantum mechanics, QSimulate’s platform facilitates quantum molecular simulations, allowing clients to tackle industrial-scale problems more effectively. The tools offered by the company automate workflows, relieving computational scientists of routine tasks and thereby increasing productivity. This innovation enables organizations to accelerate their research and development processes, ultimately enhancing their capacity to innovate and solve critical issues in their fields.
Sunlit Seedlings is a consulting firm that specializes in the diagnosis and analysis of biological communities and ecosystems. The company provides a range of services that integrate various scientific fields, including ecology, mycology, and network science. By focusing on sustainable practices, Sunlit Seedlings aims to enhance food supply systems and contribute to the stabilization of the global environment. Additionally, the firm emphasizes the importance of soil ecosystems in agricultural land, helping communities understand their ecological value and promoting sustainable agricultural practices.
Symbiobe is a company that focuses on developing a resource-recycling material production platform aimed at promoting sustainability. By utilizing underexploited natural biomass resources and photosynthetic organisms, the platform offers innovative solutions for greenhouse gas fixation and the production of industrial biopolymers, nitrogen fertilizers, and aquaculture feed. This approach not only enhances the effectiveness of these materials but also supports environmental start-up businesses in obtaining natural and sustainable products. Symbiobe's mission is to advance manufacturing practices globally to ensure a sustainable future for generations to come.
Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Viage Therapeutics is a neuroscience company established in 2018, focused on developing innovative neurotherapeutics. The company aims to address psychiatric and inflammatory diseases by discovering and creating a new class of drugs targeting conditions such as depression, anxiety, and gastrointestinal disorders. Through its groundbreaking research, Viage Therapeutics seeks to provide researchers and healthcare professionals with access to novel treatments for significant unmet medical needs in these areas.
Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.
BTB Drug Discovery Research Center aims to contribute to reducing illness and saving lives. They create the product concept (TPP) and develop the finest plans possible for R&D, intellectual property, and pharmaceutical affairs. The company is developing a therapeutic medicine using a unique mechanism of action that encourages the release of endogenous opioids.
Myoridge Co. Ltd. is a biotechnology company based in Kyoto, Japan, that focuses on developing innovative solutions for cell differentiation and drug research. Established in 2016, the company specializes in a suspension culture system that facilitates the scalable differentiation of pluripotent cells into cardiomyocytes without the need for proteins, utilizing a novel small-molecule compound. Myoridge produces iPS cell-derived cardiomyocytes and cardiomyocyte fibers, which are characterized by high maturity and purity, offering excellent drug response rates. Their products also include software for analyzing myocardial motion and fluorescence. By employing a protein-free medium for cell culture, Myoridge achieves low production costs and lot-to-lot uniformity while closely approximating the characteristics of mature human cardiomyocytes. This approach supports advancements in regenerative medicine and drug development technologies.
Melody International is a manufacturing company that specializes in medical equipment designed for remote medical services. The company has developed an advanced fetal monitoring device that assists healthcare professionals during challenging delivery situations. This device includes a fetal heart monitor, a uterine contraction monitor, and a tablet interface. It features a built-in speaker connected to the transducer via the internet, allowing it to function as a fetal Doppler for monitoring pregnancy. This innovation enables women to assess maternal and fetal health conditions even from distant locations, thereby improving access to essential medical care.
Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, the company focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. Cuorips is involved in the manufacturing and sales of cellular and tissue-based products, as well as providing contract development and manufacturing services. The company aims to advance medical treatments through innovative cell products and therapies.
PePerseus Proteomics is a drug discovery biotechnology venture that uses advanced antibody technology to pursue superior antibody production technology and create new medicines powerfully for people around the world who are waiting for better medical care .
Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.
Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).
U-Map is an industrial materials venture originating from Nagoya University, primarily established by its researchers. The company focuses on addressing global challenges in manufacturing processes through the development of innovative conductive materials. U-Map specializes in aluminum-based synthesis technologies that offer high thermal conductivity and insulating properties. By commercializing advanced university research, the company aims to provide solutions that enhance product quality and sustainability across various industries. Through its commitment to technological innovation, U-Map seeks to foster the creation of next-generation industries.
Rege Nephro Co., Ltd., established in 2019 and based in Kyoto, Japan, is a biotech company focused on the research, development, production, and marketing of therapeutics for renal diseases. The company leverages induced pluripotent stem cell (iPSC) technology, sourced from the Center for iPS Cell Research and Application at Kyoto University, to create innovative treatments for kidney, liver, and pancreas conditions. Rege Nephro develops drugs that utilize core seeds technology, which includes pluripotent stem cells capable of producing erythropoietin (EPO) and specific nephron progenitor cell markers. This approach aims to minimize the reliance on dialysis among patients with renal failure by offering effective therapeutic alternatives. Additionally, the company produces kidney organoids designed for nephrotoxicity screening, facilitating drug discovery in applied research.
Fimecs is a biotechnology firm specializing in drug discovery through protein degradation technology. The company focuses on developing innovative therapeutics aimed at treating cancers and other challenging diseases. Fimecs utilizes a drug discovery platform that operates on a ubiquitin E3 ligase binder, which facilitates the design of small molecules that induce the degradation of specific, disease-related proteins. While the human body contains over 18,000 proteins, approximately 1,500 are linked to various diseases, yet only around 300 have been identified as viable targets for small molecule drug interventions. Fimecs aims to expand the possibilities of druggable targets by addressing these previously undruggable proteins, ultimately seeking to enhance treatment options for patients.
EneCoat Technologies specializes in the development and manufacturing of perovskite solar cells and related materials. The company focuses on creating thin-film solar cells that perform effectively in low-light conditions, aiming to enhance the utilization of natural energy sources while contributing to environmental protection. By commercializing these advanced solar modules, EneCoat seeks to facilitate accessible and efficient solar energy generation for businesses, thereby promoting a sustainable energy future.
tiem factory is a developer of ultra-light transparent insulation material intended to be used as a thermal insulation material. The company's ultra-light transparent insulation material can be made without using supercritical dryer, enabling its clients to receive insulation material composed of air.
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.
LegalOn is the global leader in AI contract review, helping over 5,000 companies and firms worldwide review and negotiate stronger contracts up to 85% faster and more accurately. Built by lawyers for legal teams, LegalOn’s AI is anchored in accurate and up-to-date legal knowledge from experienced attorneys. LegalOn’s AI detects contract risks, makes precise redlines, and adapts to each organization’s unique standards and preferences. With it, legal and business teams can save significant time, reduce legal risk at scale, and break free from tedious work. Focus on the strategic work you love and your business needs, and let LegalOn handle the rest. LegalOn offers a complete AI contract review solution with an unmatched collection of customizable playbooks that deliver immediate real-world value. Speed up review and redlining, streamline search, storage, and comparison, and get answers to any contract question with our AI assistant—both online and directly integrated within Microsoft Word. Founded in 2017, LegalOn is backed by $130M in funding from leading investors including Goldman Sachs, Sequoia, and SoftBank. LegalOn operates globally with businesses in the US and Japan.
Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.
Myoridge Co. Ltd. is a biotechnology company based in Kyoto, Japan, that focuses on developing innovative solutions for cell differentiation and drug research. Established in 2016, the company specializes in a suspension culture system that facilitates the scalable differentiation of pluripotent cells into cardiomyocytes without the need for proteins, utilizing a novel small-molecule compound. Myoridge produces iPS cell-derived cardiomyocytes and cardiomyocyte fibers, which are characterized by high maturity and purity, offering excellent drug response rates. Their products also include software for analyzing myocardial motion and fluorescence. By employing a protein-free medium for cell culture, Myoridge achieves low production costs and lot-to-lot uniformity while closely approximating the characteristics of mature human cardiomyocytes. This approach supports advancements in regenerative medicine and drug development technologies.
Luxonus is a medical device manufacturing company specializing in photoacoustic technology aimed at early disease detection and diagnosis. The company has developed an advanced imaging device that utilizes optical ultrasonic technology, which combines light and ultrasonic waves to create ultra-high-resolution three-dimensional images of blood vessels and lymphatic vessels. This innovative approach allows for safe and easy imaging without exposure, providing healthcare professionals with a comprehensive understanding of disease onset, healing processes, and overall health conditions before and after illness.
Thyas Co. Ltd. specializes in regenerative immunocell therapy aimed at treating cancer and infectious diseases. The company has developed a method for creating regenerative T cells from human induced pluripotent stem (iPS) cells. By offering personalized regenerative immuno-cell therapy, Thyas focuses on enhancing treatment options for patients battling cancer and various infections. Through its innovative approach, the company seeks to improve patient outcomes and contribute to advancements in cancer treatment and immunology.
Algal Bio Co., Ltd., established in 2018 and based in Kashiwa, Japan, specializes in the research, development, production, and sale of algae and its components. Drawing on two decades of research from the University of Tokyo, the company focuses on producing rare fatty acids and carotenoids while also engaging in food processing, importing, exporting, and distributing algae and its ingredients. Algal Bio operates a laboratory dedicated to exploring the functionality of microalgae as food ingredients, employing a unique algae bio-foundry platform that integrates various screening and cultivation technologies. The company aims to address significant global challenges, including rising health consciousness, food shortages, and climate change, by applying algae across diverse industries and applications.
aceRNA Technologies is a biotechnology startup focused on developing innovative genetic therapies utilizing RNA switch technology. The company specializes in regenerative medicine, aiming to discover novel functions of microRNAs (miRNAs) that can regulate gene expression. By harnessing this technology, aceRNA Technologies seeks to facilitate the removal of undifferentiated and potentially cancerous cells, thereby enhancing drug discovery and therapeutic applications. Through its patient-centric approach, the company strives to advance the field of genetic therapies and improve treatment outcomes in various medical conditions.
Thyas Co. Ltd. specializes in regenerative immunocell therapy aimed at treating cancer and infectious diseases. The company has developed a method for creating regenerative T cells from human induced pluripotent stem (iPS) cells. By offering personalized regenerative immuno-cell therapy, Thyas focuses on enhancing treatment options for patients battling cancer and various infections. Through its innovative approach, the company seeks to improve patient outcomes and contribute to advancements in cancer treatment and immunology.
Space Power Technologies (SPT) was founded in 2019 as Japan's first start-up for “Spatial Transmission Wireless Power Transmission (WPT)”. We will harmonize elemental technologies cultivated through academics with people and society, and solve social issues related to power supply.
Kyulux, Inc. is a company based in Fukuoka, Japan, specializing in the research and development of organic electroluminescence materials for organic light-emitting diode (OLED) displays and lighting. Founded in 2015, Kyulux focuses on developing thermally activated delayed fluorescence (TADF) technology and offers a product known as Hyperfluorescence, which combines TADF with fluorescence emitters to enhance emission efficiency. The company holds an extensive intellectual property portfolio related to TADF, largely developed through collaborations with Kyushu University and industrial partners over the past seven years. By providing these innovative OLED materials, Kyulux enables manufacturers in the display and lighting sectors to create cost-effective, durable, and efficient products without relying on rare metals.
On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.
Sho Engineering is a company that specializes in planning, research, and product development within the field of wireless transmission equipment. It aims to enhance safety and comfort in society through innovative technology. The company's products include a data transmitter powered by wireless energy, which facilitates the transmission of data, wireless power, and data transfer through devices designed for long-distance identity card services. Additionally, Sho Engineering has developed an emergency and volcano observation monitoring assistance system, providing clients with advanced solutions to enhance safety and security in various scenarios.
AlphaNavi Pharma Co., Ltd. is a biotechnology company based in Kyoto, Japan, founded in 2019. It focuses on drug discovery and the development of innovative pain therapeutics, specifically targeting peripheral neuropathic pain through its products ANP-230 and ANP-231, which are voltage-gated sodium channel selective inhibitors. The company is committed to advancing research and clinical development by collaborating with academia, investors, and healthcare professionals. Through these partnerships, AlphaNavi Pharma aims to create new value in the field of pain management, ultimately helping to alleviate suffering and improve the quality of life for patients and their families.
Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company focuses on the research and development of innovative oncology drugs aimed at addressing significant unmet medical needs in cancer treatment. Chordia Therapeutics is dedicated to delivering first-in-class therapeutic options to patients, emphasizing the importance of advancing cancer care through its specialized bioventure efforts.
Luxonus is a medical device manufacturing company specializing in photoacoustic technology aimed at early disease detection and diagnosis. The company has developed an advanced imaging device that utilizes optical ultrasonic technology, which combines light and ultrasonic waves to create ultra-high-resolution three-dimensional images of blood vessels and lymphatic vessels. This innovative approach allows for safe and easy imaging without exposure, providing healthcare professionals with a comprehensive understanding of disease onset, healing processes, and overall health conditions before and after illness.
SOUSEI Technology, Inc. specializes in developing software and hardware solutions for home design and management. Founded in 2018 and based in Tokyo, Japan, the company offers an Internet of Things (IoT) device called v-ex, which enables homeowners to communicate with their home electronics through voice commands. Additionally, SOUSEI Technology provides an online platform named Knot, designed to facilitate connections between housing companies and homeowners. This platform allows housing companies to efficiently manage customer and property information, as well as documentation related to security and compliance. The company's focus on user experience design and artificial intelligence supports its mission to enhance management and product development in the housing sector.
LegalOn is the global leader in AI contract review, helping over 5,000 companies and firms worldwide review and negotiate stronger contracts up to 85% faster and more accurately. Built by lawyers for legal teams, LegalOn’s AI is anchored in accurate and up-to-date legal knowledge from experienced attorneys. LegalOn’s AI detects contract risks, makes precise redlines, and adapts to each organization’s unique standards and preferences. With it, legal and business teams can save significant time, reduce legal risk at scale, and break free from tedious work. Focus on the strategic work you love and your business needs, and let LegalOn handle the rest. LegalOn offers a complete AI contract review solution with an unmatched collection of customizable playbooks that deliver immediate real-world value. Speed up review and redlining, streamline search, storage, and comparison, and get answers to any contract question with our AI assistant—both online and directly integrated within Microsoft Word. Founded in 2017, LegalOn is backed by $130M in funding from leading investors including Goldman Sachs, Sequoia, and SoftBank. LegalOn operates globally with businesses in the US and Japan.
EneCoat Technologies specializes in the development and manufacturing of perovskite solar cells and related materials. The company focuses on creating thin-film solar cells that perform effectively in low-light conditions, aiming to enhance the utilization of natural energy sources while contributing to environmental protection. By commercializing these advanced solar modules, EneCoat seeks to facilitate accessible and efficient solar energy generation for businesses, thereby promoting a sustainable energy future.
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.
Mitsucari is an HR technology service company that specializes in optimizing organizational dynamics through an in-depth analysis of individual personality traits and compatibility. It has developed a candidate verification platform that matches job seekers' personalities and values with the corporate culture of potential employers. This platform employs aptitude tests for job seekers while simultaneously assessing current employees to gauge the corporate environment. By identifying personality alignments and preferred working conditions, Mitsucari aims to enhance job matching, facilitating better employment outcomes for candidates and promoting employee retention for organizations.
aceRNA Technologies is a biotechnology startup focused on developing innovative genetic therapies utilizing RNA switch technology. The company specializes in regenerative medicine, aiming to discover novel functions of microRNAs (miRNAs) that can regulate gene expression. By harnessing this technology, aceRNA Technologies seeks to facilitate the removal of undifferentiated and potentially cancerous cells, thereby enhancing drug discovery and therapeutic applications. Through its patient-centric approach, the company strives to advance the field of genetic therapies and improve treatment outcomes in various medical conditions.
Connexx Systems is a company focused on developing core battery technologies that enhance electric power generation and storage systems. By integrating storage devices with renewable energy sources, such as solar and wind power, the company aims to provide users with alternative energy solutions. This innovation facilitates efficient energy use and contributes to sustainable power generation, positioning Connexx Systems as a key player in the transition to cleaner energy sources.
Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, the company focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. Cuorips is involved in the manufacturing and sales of cellular and tissue-based products, as well as providing contract development and manufacturing services. The company aims to advance medical treatments through innovative cell products and therapies.
Sho Engineering is a company that specializes in planning, research, and product development within the field of wireless transmission equipment. It aims to enhance safety and comfort in society through innovative technology. The company's products include a data transmitter powered by wireless energy, which facilitates the transmission of data, wireless power, and data transfer through devices designed for long-distance identity card services. Additionally, Sho Engineering has developed an emergency and volcano observation monitoring assistance system, providing clients with advanced solutions to enhance safety and security in various scenarios.
LegalForce, Inc., founded in 2017 and headquartered in Toyosu, Tokyo, Japan, specializes in developing and maintaining AI-powered software for legal services, particularly in contract management. The platform employs natural language processing and other advanced technologies to assist legal professionals by reviewing contracts based on their type, identifying potentially omitted or risky clauses, and minimizing oversights. This functionality aims to enhance the quality and efficiency of legal operations, providing valuable support in the contract review process.
LegalOn is the global leader in AI contract review, helping over 5,000 companies and firms worldwide review and negotiate stronger contracts up to 85% faster and more accurately. Built by lawyers for legal teams, LegalOn’s AI is anchored in accurate and up-to-date legal knowledge from experienced attorneys. LegalOn’s AI detects contract risks, makes precise redlines, and adapts to each organization’s unique standards and preferences. With it, legal and business teams can save significant time, reduce legal risk at scale, and break free from tedious work. Focus on the strategic work you love and your business needs, and let LegalOn handle the rest. LegalOn offers a complete AI contract review solution with an unmatched collection of customizable playbooks that deliver immediate real-world value. Speed up review and redlining, streamline search, storage, and comparison, and get answers to any contract question with our AI assistant—both online and directly integrated within Microsoft Word. Founded in 2017, LegalOn is backed by $130M in funding from leading investors including Goldman Sachs, Sequoia, and SoftBank. LegalOn operates globally with businesses in the US and Japan.
AFI Technology, established on December 23, 2013, in Seoul, Korea, specializes in manufacturing and selling innovative inspection and monitoring technology products primarily for the food and life science industries. The company offers electric filter separation technology and rapid detection systems that address microbial contamination risks, allowing clients to enhance food safety. With a strong emphasis on environmental responsibility, AFI responds to diverse needs in rapid microbiological testing and other technology solutions, underscoring its commitment to providing effective and efficient products for its clientele.
Questetra, Inc. is an enterprise cloud computing company based in Kyoto, Japan, established in 2008. It specializes in providing business process management (BPM) tools designed to enhance productivity and optimize workflows for various organizations. The Questetra BPM Suite enables users to develop BPMN-driven workflows through a user-friendly, web-based interface, allowing for both process design and task execution directly in a browser. The platform supports various business processes, such as estimating, invoice issuing, and inquiry responses, and offers integration with Google Apps for seamless user access and data export to Google Docs. Additionally, Questetra provides BPM consulting services to further assist organizations in improving their operational efficiency.
Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company focuses on the research and development of innovative oncology drugs aimed at addressing significant unmet medical needs in cancer treatment. Chordia Therapeutics is dedicated to delivering first-in-class therapeutic options to patients, emphasizing the importance of advancing cancer care through its specialized bioventure efforts.
Thyas Co. Ltd. specializes in regenerative immunocell therapy aimed at treating cancer and infectious diseases. The company has developed a method for creating regenerative T cells from human induced pluripotent stem (iPS) cells. By offering personalized regenerative immuno-cell therapy, Thyas focuses on enhancing treatment options for patients battling cancer and various infections. Through its innovative approach, the company seeks to improve patient outcomes and contribute to advancements in cancer treatment and immunology.
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.
Oligogen is a bio-venture based in Kyoto, Japan, founded in 2015. The company focuses on drug development and regenerative medicine, specifically utilizing neural stem cell technologies to create therapies for patients with central nervous system diseases. Oligogen aims to treat conditions such as spinal cord injuries and other neurological disorders, including congenital leukoplakia and multiple sclerosis. By harnessing the potential of human neural stem cells, Oligogen seeks to provide effective cell therapies that enhance neurological healthcare for affected individuals.
Thyas Co. Ltd. specializes in regenerative immunocell therapy aimed at treating cancer and infectious diseases. The company has developed a method for creating regenerative T cells from human induced pluripotent stem (iPS) cells. By offering personalized regenerative immuno-cell therapy, Thyas focuses on enhancing treatment options for patients battling cancer and various infections. Through its innovative approach, the company seeks to improve patient outcomes and contribute to advancements in cancer treatment and immunology.
Connexx Systems is a company focused on developing core battery technologies that enhance electric power generation and storage systems. By integrating storage devices with renewable energy sources, such as solar and wind power, the company aims to provide users with alternative energy solutions. This innovation facilitates efficient energy use and contributes to sustainable power generation, positioning Connexx Systems as a key player in the transition to cleaner energy sources.
NS Materials Corp. is a manufacturer and distributor of semiconductor-related equipment and systems based in Chikushino-shi, Japan. The company focuses on developing micro-space chemical technologies, particularly specializing in nano-phosphor for LED lighting and innovative chemical synthesis techniques. By advancing these technologies, NS Materials aims to establish a new field within nanotechnology and biotechnology. Their offerings are designed to provide clients with tools and products that contribute to a low-carbon society, significantly impacting daily life and promoting sustainability.
FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).
tiem factory is a developer of ultra-light transparent insulation material intended to be used as a thermal insulation material. The company's ultra-light transparent insulation material can be made without using supercritical dryer, enabling its clients to receive insulation material composed of air.
Audio Metaverse, known as Cubemint, operates at the intersection of physical reality and virtual environments by creating immersive 3D audio spaces. This platform allows users to mint NFTs and explore these audio realms collectively, enhancing their interaction with both digital and physical assets. The company specializes in an audio streaming application designed to foster real-time conversations among friends and followers. By integrating augmented audio reality, Cubemint facilitates live streaming sessions that can last for several hours, enabling users to engage with one another through comments and discussions. This innovative approach allows individuals to experience and share their ideas authentically while navigating between physical spaces and their corresponding digital audio environments.
PrediXT is a developer of prediction technologies.
Mitsucari is an HR technology service company that specializes in optimizing organizational dynamics through an in-depth analysis of individual personality traits and compatibility. It has developed a candidate verification platform that matches job seekers' personalities and values with the corporate culture of potential employers. This platform employs aptitude tests for job seekers while simultaneously assessing current employees to gauge the corporate environment. By identifying personality alignments and preferred working conditions, Mitsucari aims to enhance job matching, facilitating better employment outcomes for candidates and promoting employee retention for organizations.
Lang-8 is a language exchange website Native speakers will help you correct journal entries in the language that you're learning, and you can do the same to help them out as well. If you're learning another language, whether you are a beginner, intermediate, or advanced, there is no better way than interacting with native speakers of the language that you're learning. Here's how Lang-8 works. 1) Write Journal Entries in the Language that You're Learning: Lang-8 makes it easy to write entries, reviews, and more in the language that you're learning. It's a great way to get better quickly. 2) Native Speakers Correct Your Entries: Whenever you write something new, native speakers come in and correct your entries. Corrections are easy to see and understand so you can learn as much as possible. 3) Help Others: The Lang-8 community is super-friendly. Come join us and see for yourself! More than 70 languages are available in Lang-8. We have users from 180 Countries.
They are engaged in close research and development based on joint research contracts with universities, and they aim to develop clinical drugs with few side effects by utilizing know-how of phosphoenzyme inhibitor research. In addition, they are working on the development of therapeutic agents for intractable diseases such as viral diseases and neurodegenerative diseases, which target kinases.
KDDD develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
AFI Technology, established on December 23, 2013, in Seoul, Korea, specializes in manufacturing and selling innovative inspection and monitoring technology products primarily for the food and life science industries. The company offers electric filter separation technology and rapid detection systems that address microbial contamination risks, allowing clients to enhance food safety. With a strong emphasis on environmental responsibility, AFI responds to diverse needs in rapid microbiological testing and other technology solutions, underscoring its commitment to providing effective and efficient products for its clientele.
Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.